IMARC Group, a leading market research company, has recently releases report titled “Protein Engineering Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global protein engineering market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights

How Big is the Protein Engineering Market?

The global protein engineering market size reached US$ 3.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 5.7 Billion by 2028, exhibiting a growth rate (CAGR) of 11.2% during 2023-2028.

What is Protein Engineering?

Protein engineering refers to the process of designing and modifying proteins for specific applications. It comprises various technologies, such as rational design, directed evolution, and computational design. It involves a synthesis of new proteins or amendment in the existing protein sequence or structure to achieve improved functions. It is widely utilized for drug development, biocatalysis, biosensors, and materials science. As a result, protein engineering is employed in pharmaceutical and biotechnology companies, academic institutions, and contract research organizations (CROs) across the globe. 

Request Free Sample Copy of This Report: https://www.imarcgroup.com/protein-engineering-market/requestsample

What are the growth prospects and trends in the protein engineering industry?

Presently, the rising prevalence of protein-deficient diseases, such as kwashiorkor and marasmus, among the masses represents one of the primary factors strengthening the growth of the market. In addition, the growing demand for alternatives to chemical processes is offering a positive market outlook.

Apart from this, governing agencies of various countries are offering various initiatives to enhance protein engineering capabilities, which is bolstering the growth of the market. Moreover, the rising expenditure on healthcare infrastructure, along with the inflating income levels of individuals, is offering lucrative growth opportunities to industry players.

Furthermore, the rising utilization of protein engineering to overcome drug-related defects and can enhance the effectiveness of molecules for various purposes is supporting the growth of the market.         

What is included in market segmentation?

The report has segmented the market into the following categories:

• Breakup by Product & Services:

  • Instruments
  • Reagents
  • Services and Software

  Breakup by Protein Type:

  • Insulin
  • Monoclonal Antibodies
  • Coagulation Factors
  • Vaccines
  • Growth Factors
  • Others

  Breakup by Technology:

  • Irrational Protein Design
  • Rational Protein Design

  Breakup by End User:

  • Pharmaceutical and Biotechnology Companies
  • Academic Research Institutes
  • Contract Research Organizations

Market Breakup by Region:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

Who are the key players operating in the industry?

The report covers the major market players including:

Abzena Ltd., Agilent Technologies Inc., Amgen Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Codexis Inc., Danaher Corporation, Eli Lilly and Company, General Electric Company, Merck KGaA, Novo Nordisk A/S, PerkinElmer Inc., Thermo Fisher Scientific Inc. and Waters Corporation.

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Email: [email protected]

Follow us on Twitter: @imarcglobal

LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/